RespireRx Pharmaceuticals Inc (RSPI)

[neuroinv]

This came up previously, perhaps 18 months ago. Cortex controls the compounds developed inhouse. As was also discussed a while back, University of California had to agree to extend the timeline on Cortex's license, and chose to do so (I think this was in 2007). So the UC's judgment was that they were better off with Cortex working to commercialize the IP than trying to find someone else to do so (and without access to Cortex-owned compounds).

NeuroInvestment